Research & Development

Can Congress Improve Veterans’ Access to Non-VA Care?
Research & Development Can Congress Improve Veterans’ Access to Non-VA Care?

Picture a veteran, a Marine Corps and Army hero like John-Paul Sager, sitting in a small-town clinic just miles from home, yet unable to get treatment for chronic pain without wading through a swamp of paperwork and approvals. Across the nation, thousands of veterans face this reality, driving past

Trend Analysis: Flavonols in Drug Resistance Solutions
Research & Development Trend Analysis: Flavonols in Drug Resistance Solutions

In an era where medical advancements are constantly tested by evolving health challenges, drug resistance stands as a formidable barrier, impacting millions of patients worldwide with a staggering failure rate in treatments like chemotherapy, where up to 50% of cases show reduced efficacy due to

Can Starfish Compounds Defeat Drug-Resistant Prostate Cancer?
Research & Development Can Starfish Compounds Defeat Drug-Resistant Prostate Cancer?

Imagine a world where a solution to one of the deadliest cancers among men lies hidden beneath the ocean's surface, offering hope to those battling prostate cancer. This disease, claiming over 375,000 lives globally each year, often evolves into drug-resistant forms that defy conventional

Glucose Boosts T Cells’ Tumor-Fighting Power with GSLs
Research & Development Glucose Boosts T Cells’ Tumor-Fighting Power with GSLs

I'm thrilled to sit down with Ivan Kairatov, a leading biopharma expert with extensive experience in research and development, particularly in the intersection of technology and innovation in the industry. Today, we’re diving into groundbreaking insights on how T cells, crucial players in our

Flavonoids Show Promise in GI Cancer Treatment via Ferroptosis
Research & Development Flavonoids Show Promise in GI Cancer Treatment via Ferroptosis

In a world where gastrointestinal (GI) cancers continue to pose a formidable challenge to global health, a groundbreaking study from researchers at Weill Cornell Medicine-Qatar has unveiled a potential game-changer in cancer therapy. GI cancers, encompassing colorectal, stomach, liver, esophageal,

Can Miricorilant Revolutionize MASH Treatment in Trials?
Research & Development Can Miricorilant Revolutionize MASH Treatment in Trials?

In the realm of liver disease research, metabolic-associated steatohepatitis (MASH), a severe form of fatty liver disease also known as metabolic dysfunction-associated steatotic liver disease (MASLD), stands as a formidable challenge with potentially devastating consequences. Characterized by

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later